Fosun Pharma has divested a 6% stake in Gland Pharma for Rs 1,754 crore through an open market transaction, reducing its shareholding to 51.86%. UBS Principal Capital Asia acquired a 0.5% stake.
New Delhi, Jun 19 (PTI) Fosun Pharma, one of the promoters of Gland Pharma, on Wednesday divested a 6 per cent stake for Rs 1,754 crore through an open market transaction.
Chinese drug firm Fosun Pharma, through its arm Fosun Pharma Industrial Pte, offloaded the shares of Hyderabad-based Gland Pharma through a bulk deal on the BSE.
According to the bulk deal data available on the BSE, Fosun Pharma Industrial Pte disposed of 99 lakh shares or a 6 per cent stake in Gland Pharma.
The shares were sold at an average price of Rs 1,771.81 apiece, taking the deal size to Rs 1,754.09 crore.
After the stake sale, Fosun Pharma's shareholding in Gland Pharma has declined to 51.86 per cent from 57.86 per cent.
Meanwhile, UBS Principal Capital Asia picked up 8.25 lakh shares, amounting to a 0.5 per cent stake in Gland Pharma.
The shares were purchased at an average price of Rs 1,771.05 per piece, taking the transaction value to Rs 146.11 crore.
Details of the other buyers of Gland Pharma's shares could not be ascertained.
Shares of Gland Pharma fell 0.65 per cent to close at Rs 1,826.60 apiece on the BSE.
In October 2017, Fosun Pharma acquired approximately 74 per cent of Gland Pharma at a valuation of not more than USD 1.09 billion.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback